NunaBio raises £6.5m led by Northstar Ventures to manufacture high fidelity synthetic DNA at scale

NunaBio develops an enzymatic DNA synthesis platform that manufactures high fidelity synthetic DNA at scale. The platform enables customers in sectors such as medicine, biotechnology and diagnostics to access complex DNA formats that are difficult to produce using traditional methods.